安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Treat Recurrent Pericarditis with ARCALYST® (rilonacept)
ARCALYST ® (rilonacept) is an interleukin-1 blocker indicated for: Treatment of Recurrent Pericarditis (RP) and reduction in risk of recurrence in adults and pediatric patients 12 years and older Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS), and Muckle-Wells Syndrome
- Arcalyst: Uses, Dosage, Side Effects, Warnings - Drugs. com
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of Interleukin-1 Receptor Antagonist, and recurrent pericarditis Includes Arcalyst side effects, interactions and indications
- ARCALYST (rilonacept) Injection Dosing Administration | Arcalyst HCP
ARCALYST is a patient-administered, once-weekly, subcutaneous injection for recurrent pericarditis Learn about dosing options for adults and adolescents
- FDA approves first treatment for disease that causes recurrent . . .
FDA has approved Arcalyst (rilonacept) injection to treat recurrent pericarditis and reduce the risk of recurrence in adults and children 12 years and older
- Arcalyst (Rilonacept): Side Effects, Uses, Dosage . . . - RxList
ARCALYST® (rilonacept) is an interleukin-1 blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS), and Muckle-Wells Syndrome (MWS) in adults and pediatric patients 12 years and older
- Arcalyst Autoimmune Disorder Medication Side Effects Dosage - MedicineNet
Arcalyst is a prescription medicine called an interleukin-1 (IL-1) blocker Arcalyst is indicated for the treatment of recurrent pericarditis (RP) and reduction in risk of recurrence in adults and pediatric patients 12 years and older
- How Arcalyst Treats and Prevents Recurrent Pericarditis - WebMD
Arcalyst works to treat pericarditis and prevent flare-ups by decreasing inflammation around your heart You should start to notice your symptoms improving and have fewer flare-ups
- Arcalyst (rilonacept) dosing, indications, interactions, adverse . . .
Indicated for maintenance of remission of deficiency of interleukin-1 receptor antagonist (DIRA) 4 4 mg kg (not to exceed 320 mg) SC once weekly Indicated to treat recurrent
|
|
|